GPRC5A and metastatic neoplasm: Since GPRC5A remains uncharacterized in clinical HGSC, we performed histological analysis of tissue microarrays (TMA) containing samples from primary and metastatic tumors of 126 treatment‐naïve HGSC patients (Fig 9A, Appendix Table S1).